CClinicalTrials.gg
Status unknownNCT04780997Updated Mar 4, 2021

The Effect of Virtual Reality Exercises on Balance in Patients With Osteoporosis

An interventional study of Virtual Reality in Osteoporosis, sponsored by Nigde Omer Halisdemir University. Status unknown. Open to female participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2021-03-04.

Sponsored by Nigde Omer Halisdemir University · Not applicable, Interventional, and Screening

The sponsor has not verified this record recently (last verified Mar 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
50 Years and older
Sex
Female
01

Study summary

Osteoporosis is a systemic disease characterized by low bone mass and increased bone fragility and increased fracture likelihood as a result of deterioration of the bone tissue microstructure.One of the important conditions determining the fracture risk in osteoporosis patients is fall. Balance exercises are perform to reduce the risk of falling.Virtual reality games are used in balance studies in many rehabilitation areas. The aim of this study is to investigate the effect of virtual reality exercises on balance.

Read the detailed description

Osteoporosis is a systemic disease characterized by low bone mass and increased bone fragility and increased fracture likelihood as a result of deterioration of the bone tissue microstructure.One of the important conditions determining the fracture risk in osteoporosis patients is fall. Balance exercises are perform to reduce the risk of falling.Virtual reality games are used in balance studies in many rehabilitation areas. The aim of this study is to investigate the effect of virtual reality exercises on balance patients with osteoporozis.

02

Conditions studied

  • Osteoporosis

Browse trials for

03

In context

Osteoporosis

1,640 studies on the registry are indexed under Osteoporosis; 212 are open to participants now.

This study's planned enrollment of 20 is below the median of 95 across 1,133 interventional studies indexed under Osteoporosis.

Browse Osteoporosis studies →

Lead sponsor

Nigde Omer Halisdemir University is the lead sponsor of 89 studies on the registry; 30 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • diagnosed with primary osteoporosis

Exclusion criteria

Exclusion Criteria:

  • history of inflammatory rheumatic disease
  • history of vestibular and cerebellar disease
  • diseases affecting the central and peripheral nervous system (Parkinson's, stroke, ataxia, dementia, multiple sclerosis, peripheral neuropathy
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Virtual Realty

    Microsoft Xbox Kinect® was used for virtual reality exercises

    Other: Virtual Reality

Interventions

  • OtherVirtual Reality

    Microsoft Xbox Kinect® was used for virtual reality exercises

06

What researchers measure

Primary outcomes

  1. Static balance index

    Postural balance was measured using the Biodex Balance System (BBS) (Biodex Medical Systems, Shirley, NY), a movable balance platform that provides up to 20 of surface tilt in a 360 range of motion. The platform is interfaced with computer software (Biodex, Version 3.1, Biodex Medical Systems) that enables the device to serve as an objective assessment of balance

    Time frame: 4th week

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 4, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04780997
Lead sponsor
Nigde Omer Halisdemir University
Responsible party
MUSA POLAT (Asst.Prof.Dr, Nigde Omer Halisdemir University) — Principal investigator
First posted
Mar 4, 2021
Start date
Apr 1, 2021 (estimated)
Primary completion
Aug 30, 2021 (estimated)
Completion
Oct 1, 2021 (estimated)
Last update
Mar 4, 2021

Study contacts

Musa Polat
Contact
musa.polat.sfl@gmail.com
05058634671
Musa Polat
principal investigator · Niğde OHÜ

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion